STAR-0602
Marengo Therapeutics
[]
#sitc22 i am delighted to introduce to you star0602, a novel, bispecific t-cell receptor (tcr) agonist antibody that selectively targets and activates a subset of v t-cells. it has just been cleared for a clinical trial (nct05592626) that we plan to open at . 